Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions
3 other identifiers
interventional
16
1 country
1
Brief Summary
This clinical trial studies the effect of an interdisciplinary program with strong patient involvement on managing long-term chronic pain for cancer survivors. The purpose of this study is to determine whether enrolling patients into an interdisciplinary program can improve mobility with physical and occupational therapy and participation in online group psychotherapy that teaches coping skills to enhance quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2021
CompletedStudy Start
First participant enrolled
July 21, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2024
CompletedMay 29, 2024
May 1, 2024
2.8 years
July 1, 2021
May 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of Functional Restoration Program
Feasibility of the program will be determined by the proportion of referred eligible cancer survivors enrolled into the program (at least 50% who are eligible enroll) and the proportion of enrolled patients completed at least half of the intervention.
24 months from the intervention date
Other Outcomes (6)
Preliminary effect of the Functional Restoration Program in reducing pain (NSR)
Pre-intervention , End of intervention (6 weeks), 3 months post-intervention
Preliminary effect of the Functional Restoration Program in reducing pain (PSEQ)
Pre-intervention, End of intervention (6 weeks), 3 months post-intervention
Preliminary effect of the Functional Restoration Program to restore physical function (ADL)
Pre-intervention, End of intervention (6 weeks), 3 months post-intervention
- +3 more other outcomes
Study Arms (1)
Supportive care (cancer pain rehabilitation program)
EXPERIMENTALPatients participate in the cancer pain rehabilitation program for 6 weeks, including educational sessions over 2 hours once weekly, group psychological interventions, group physical therapy, and 1:1 physical and occupational therapy treatment per the patient's treatment plan. Patients may also undergo osteopathic manual treatments per physical and occupational therapy assessments.
Interventions
Participate in group psychological intervention
Attend educational session
Undergo osteopathic manual treatments
Participate in occupational therapy
Participate in physical activity
Participate in physical therapy
Ancillary studies
Eligibility Criteria
You may qualify if:
- This study will be conducted in those with history of cancer in remission or with stable disease living with chronic pain greater than 6 months in duration
- Cancer survivors or stable indolent cancer patients ages 18 or older living with chronic pain
- All subjects must have the ability to understand and the willingness to sign a written informed consent
- Patients are required to have access to a computer with a camera and a reliable internet connection. The education lectures and psychotherapy group components of the program are facilitated via online Health Insurance Portability and Accountability Act (HIPPA) compliant platform
- Eligible participants will be able to read and write and speak English and be motivated and able to commit to attending six consecutive weekly group and individual sessions
You may not qualify if:
- Patients who are less than the age of 18 or have active problems with addiction will be excluded:
- Those identified with illicit substance abuse or addiction will be referred to an addiction specialist or medication assisted treatment program through our resource coordinator
- The substances that were considered are listed below:
- Alcohol
- Cannabis
- Hallucinogens
- Inhalants
- Opioids
- Sedatives (hypnotics or anxiolytics)
- Stimulants
- Overall, the diagnosis was based on pathological patterns of behaviors related to the use of the substance. Criteria that fit with overall groupings include impaired control, social impairment, risky use, and pharmacological criteria
- Impaired control
- The individual may express overall desire to cut down or regulate substance use and may report multiple unsuccessful efforts to decrease or discontinue use
- The individual may spend a great deal of time obtaining the substance, using the substance, or recovering from its affects
- The individual's daily activities revolve around the substance in some instances of more severe substance use disorder
- +24 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- City of Hope Medical Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
City of Hope Medical Center
Duarte, California, 91010, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather N Bitar
City of Hope Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2021
First Posted
September 5, 2021
Study Start
July 21, 2021
Primary Completion
May 6, 2024
Study Completion
May 6, 2024
Last Updated
May 29, 2024
Record last verified: 2024-05